Jon is a Senior Analyst at Asymmetry Group supporting clients across rare disease commercialization, launch planning, and commercial transformation initiatives. He brings a structured, execution-oriented approach to helping teams navigate complex commercial challenges.
Jon has contributed to launch strategy and commercialization efforts across a broad range of rare disease programs. His experience includes customer journey strategy, sales enablement, value narrative development, and cross-functional coordination, enabling improved commercial decision-making and alignment.
Growing up in a family deeply embedded in healthcare, Jon saw firsthand the profound impact this work can have on people’s lives. Paired with a life-long desire to help those in need, this foundation naturally drew him to Asymmetry Group, where he channels that passion into supporting rare disease therapies and innovative products that make a real difference for underserved patient communities.
Jon holds a Bachelor of Arts degree in Economics with a minor in Finance from Boston College.